Laura E. Niklason - 03 Jun 2024 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
President, CEO and Director, Director
Signature
/s/ Laura E. Niklason by Dale A. Sander as Attorney-in-Fact
Issuer symbol
HUMA
Transactions as of
03 Jun 2024
Net transactions value
+$15,108
Form type
4
Filing time
03 Jun 2024, 16:31:36 UTC
Previous filing
04 Jun 2024
Next filing
04 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Purchase $15,108 +2,050 +0.87% $7.37 238,470 03 Jun 2024 Direct
holding HUMA Common Stock 1,148,240 03 Jun 2024 By The Niklason Living Trust F1
holding HUMA Common Stock 510,161 03 Jun 2024 By spouse
holding HUMA Common Stock 6,191,140 03 Jun 2024 By Ayabudge LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a transfer of 1,148,240 shares of common stock by Laura E. Niklason to The Niklason Living Trust on April 19, 2024, which was exempt from reporting under Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.